## Abstract Although some cardiac effects, such as palpitations and tachycardia, occur commonly in healthy people, they have also been shown to be associated with agents used to treat the myeloproliferative disorders. Various strategies exist to prevent and manage cardiac effects and minimise their
Myeloproliferative disorder therapy: assessment and management of adverse events—a psychiatrist's perspective
✍ Scribed by Graeme McDonald
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 62 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0278-0232
- DOI
- 10.1002/hon.913
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Chronic diseases such as the myeloproliferative disorders may mask a worsening emotional state in patients, which can be exacerbated by the addition of common treatments such as interferon‐α. Management of mood disturbances is best considered from the first consultation, as the negative impact of impaired emotional well‐being on physiological outcomes is well established in literature. It is therefore important for physicians to be mindful of their patients' emotional well‐being from the point of diagnosis and throughout therapy, and aware of the tendency for physicians to focus on the primary illness. The advice of a psychiatrist may prove useful when discussing management strategies for patients with identifiable mood disturbances. Copyright © 2009 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Development of cutaneous manifestations in patients with myeloproliferative disorders can be either due to the course of the disease itself or induced by some of the treatments given. The cutaneous manifestations may reveal an unknown haemopathy and/or indicate a poor prognosis. Some of
## Abstract The authors investigated the relationship between childhood abuse and obesity in young adulthood (M age = 22) in a large, U.S. representative sample (N = 15,197). Controlling for demographics and depression, men with a history of childhood sexual abuse were at increased risk of overweig